Cargando…
Der Einsatz von TNFα-Antagonisten bei primär systemischen Vaskulitiden
After the introduction of the TNFα blocking drugs Etanercept and Infliximab for the standard therapy of rheumatoid arthritis these effective substances have also been used successfully in many patients with primary systemic vasculitides, who were unresponsive to standard therapy. From pathophysiolog...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Steinkopff Verlag
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101960/ https://www.ncbi.nlm.nih.gov/pubmed/12827398 http://dx.doi.org/10.1007/s00393-003-0527-6 |